Molekule Group, Inc. Annual Deferred Income Tax Expense (Benefit) in USD from 2021 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Molekule Group, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2021 to 2022.
  • Molekule Group, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $92.8K.
  • Molekule Group, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$501K, a 56.6% decline from 2021.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.